Handrean Soran

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman et al. · New England Journal of Medicine · 2019 · 669 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet Diabetes & Endocrinology · 2018 · 331 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens et al. · Atherosclerosis · 2018 · 238 citations · Full text

Medicine, Cardiology, Genetics +11

Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome

Erik S G Stroes, Veronica Alexander, Ewa Karwatowska‐Prokopczuk et al. · New England Journal of Medicine · 2024 · 237 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16